4
Changes in Ownership
Immix Biopharma, Inc. Filed Acc 0001493152-21-032035
Chief Financial Officer bought 2,000 shares at $5.00 ($10,000)
- Chief Financial Officer acquired 320,819 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Morris Gabriel S · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-20 | Conversion : show line 1 in the form | +74,116 | $0.85 | $62,999 | 74,116 | D |
| 2021-12-20 | Conversion : show line 2 in the form | +123,527 | $0.85 | $104,998 | 123,527 | I |
| 2021-12-20 | Conversion : show line 3 in the form | +123,176 | $0.85 | $104,700 | 246,703 | I |
| 2021-12-20 | Purchase : show line 4 in the form | +2,000 | $5.00 | $10,000 | 76,116 | D |
| Open-market purchases · 2,000 sh · avg $5.00 · $10,000 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-12-20 | Conversion : show line 5 in the form Convertible Note | −0 | 0 | D |
| 2021-12-20 | Conversion : show line 6 in the form Convertible Note | −0 | 0 | I |
| 2021-12-20 | Conversion : show line 7 in the form Convertible Note | −0 | 0 | I |
Loading xslF345X03/ownership.xml…